SynthesisBMC complementary medicine and therapies2025
Effects of curcumin on serum inflammatory biomarkers in patients with knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.
Synthesis in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Effects of Curcumin on Vascular Endothelial Function, Lipid Metabolism, Inflammation and Neuroprotection-A Review.Nutrients · 2026Pooled it
- Article
- Curcumin Between Pleiotropic Potential and Translational Constraints.International journal of molecular sciences · 2026Review
- Curcumin in Inflammatory Complications: Therapeutic Applications and Clinical Evidence.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundCurcumin is a potent anti-inflammatory and antioxidant herbal medicine that has been shown to exert beneficial effects on knee osteoarthritis (OA). Previous studies revealed that curcumin had a superior effect compared to control treatments in terms of pain intensity and other patient-reported outcomes, including the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Knee Injury and Osteoarthritis Outcome Score (KOOS), visual analog scale (VAS), and Japanese Knee Osteoarthritis Measure (JKOM). However, it remains unclear whether curcumin has beneficial effects on serum inflammatory biomarkers. This systematic review and meta-analysis (SRMA) aimed to evaluate the effects of curcumin on changes in serum inflammatory biomarkers in patients with knee OA.
methodsThe PubMed, MEDLINE, Embase, Web of Science, Cochrane Library, and EBSCOhost databases were systematically searched from inception to March 28, 2025 to identify all randomized clinical trials (RCTs) that examined the use of curcumin for treating knee OA. Data related to serum inflammatory biomarkers, including C-reactive protein (CRP) levels, the erythrocyte sedimentation rate (ESR), tumor necrosis factor (TNF-alpha) levels, interleukin (IL)-1beta levels, IL-6 levels, and prostaglandin E2 (PGE-2) levels, were extracted and subjected to meta-analysis.
resultsTwenty-one studies involving 1705 patients were included. The studies were conducted across seven countries, and their sample sizes ranged from 24 to160. Meta-analysis revealed that the levels of CRP (SMD = -0.906, 95% CI = -1.543 ~ -0.269, P value = 0.005) and TNF-alpha (SMD = -0.921, 95% CI = -1.817 ~ -0.026, P value = 0.044) were significantly lower in the curcumin group than in the placebo group. However, there were no significant differences in the ESR (SMD = -0.064, 95% CI = -0.064 ~ 0.541, P value = 0.836), IL-lbeta (SMD = -0.362, 95% CI = -0.816 ~ 0.092, P value = 0.118), IL-6 level (SMD = -0.218, 95% CI = -0.806 ~ 0.370, P value = 0.467), or PGE-2 level (SMD = 0.413, 95% CI = -0.312 ~ 1.139, P value = 0.264) between the curcumin and control groups. The sensitivity test for CRP indicated that no individual study had a significant influence on the pooled results, while TNF-alpha was not as consistent as that of CRP. The visual analysis of the funnel plots revealed no publication bias.
conclusionCurcumin led to a decrease in the serum CRP and TNF-alpha levels in patients with knee OA. Additional large-scale studies or even synovial fluid analyses are recommended to further evaluate the effects of curcumin on proinflammatory biomarkers in patients with knee OA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.